Monitoring side effects of contraceptives.
D000293:Adolescent; D000328:Adult; D001943:Breast Neoplasms / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000139:chemically induced; D004341:Drug Evaluation; D004967:Estrogens / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007434:Intrauterine Devices / Q000009:adverse effects; D007880:Legislation, Drug; D008656:Mestranol / Q000009:adverse effects; D008875:Middle Aged; D010606:Pharmacy and Therapeutics Committee; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000139:chemically induced; D012189:Retrospective Studies; D013923:Thromboembolism / Q000139:chemically induced*; D013924:Thrombophlebitis / Q000139:chemically induced; D006113:United Kingdom; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced
D003276:Contraceptives, Oral; D004967:Estrogens; D004997:Ethinyl Estradiol; D008656:Mestranol